ImmunityBio reports 700% revenue growth, expands approvals globally

Go back to ImmunityBio reports 700% revenue growth, expands approvals globally
(NASDAQ: IBRX) Delayed: 7.79 -0.05 (0.64%)
Previous Close $7.84    52 Week High
Open $7.85    52 Week Low
Day High $7.95    P/E N/A 
Day Low $7.60    EPS
Volume 7,598,753